Post-earnings recap
Reported
Thu, Jul 28, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Boston Scientific's earnings report shows a positive surprise in EPS, which contributed to a 2.87% increase in stock price. The management's cautious optimism suggests they are focused on maintaining growth through innovation. However, the lack of revenue data and guidance leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.27 | N/A | +1.89% |
Management expressed satisfaction with the earnings results, highlighting their commitment to innovation. They emphasized their strategy to enhance market share.
We are pleased with our earnings performance this quarter.
Our focus remains on innovation and expanding our market presence.
Est. EPS
—
Est. Rev
—
Impl. Move
—